QY201 Tablet

· E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for QY201 Tablet, covering 2022-09-02 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Clinical Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis. [Phase 3]